Effect and Complication of Two Types of Nasogastric Tube Feeding for Elderly Dysphagia Patient After Stroke
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03844139 |
|
Recruitment Status : Unknown
Verified February 2020 by Second Affiliated Hospital, School of Medicine, Zhejiang University.
Recruitment status was: Recruiting
First Posted : February 18, 2019
Last Update Posted : February 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Deglutition Disorders | Device: Feeding pump and glycerin syringe |
| Study Type : | Observational |
| Estimated Enrollment : | 100 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Observation of Effect and Complication of Two Types of Nasogastric Tube Feeding Enteral Nutrition for Elderly Dysphagia Patients After Stroke |
| Actual Study Start Date : | February 13, 2019 |
| Estimated Primary Completion Date : | June 30, 2020 |
| Estimated Study Completion Date : | December 31, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Feeding pump group(continous)
Using the feeding pump to give patients prescribed enteral nutrient solution through nasogastric tube in 24 hours
|
Device: Feeding pump and glycerin syringe
The continuous group use feeding pump and the intermittent group use syringe to give dysphagia patients after stroke prescribed nutrition through nasogastric tube. |
|
Glycerin syringe group(intermittent)
Using the glycerin syringe to give patients prescribed enteral nutrient solution through nasogastric tube in 4-5 times
|
Device: Feeding pump and glycerin syringe
The continuous group use feeding pump and the intermittent group use syringe to give dysphagia patients after stroke prescribed nutrition through nasogastric tube. |
- weight [ Time Frame: 4-6 weeks ]weight in kilogram every week
- plasma albumin [ Time Frame: 4-6 weeks ]plasma albumin every week
- tube-feeding related complications( regurgitation, aspiration,gastric retention, diarrhea,constipation) [ Time Frame: 4-6 weeks ]incidence of each complication
- calf girth [ Time Frame: 4-6 weeks ]length of calf girth
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 65 Years to 90 Years (Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Older than 65 years old
- Clinical diagnosis of stroke( ischemic and hemorrhage)
- With moderate and/or sever swallow problem(water swallow test IV-V degree)
- With nasogastric feeding tube more than 4 weeks
- Do rehabilitation in our hospital or designated hospitals
Exclusion Criteria:
- Without nasogastric feeding tube
- Patients with fever and other infection
- Chronic or acute anoxia
- Poor obedience
- Quit treatment or go back home to take rehabilitation
- Critically ill or died
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03844139
| Contact: Zhang Yuejiao, Bachelor | +8613606525359 | 2507088@zju.edu.cn |
| China, Zhejiang | |
| Zhangy Yuejiao | Recruiting |
| Hangzhou, Zhejiang, China, 310009 | |
| Contact: Zhangy Yuejiao | |
| Responsible Party: | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| ClinicalTrials.gov Identifier: | NCT03844139 |
| Other Study ID Numbers: |
zhang yuejiao |
| First Posted: | February 18, 2019 Key Record Dates |
| Last Update Posted: | February 13, 2020 |
| Last Verified: | February 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Deglutition Disorders Esophageal Diseases Gastrointestinal Diseases Digestive System Diseases Pharyngeal Diseases |
Otorhinolaryngologic Diseases Glycerol Cryoprotective Agents Protective Agents Physiological Effects of Drugs |

